A New Combination Therapy for Scalp Alopecia Areata: A Study of High Negative Pressure Microdermabrasion and Intralesional Steroids

    M Iftikhar Sheikh
    Image of study
    TLDR Combining microdermabrasion with steroid injections improves hair regrowth in scalp alopecia areata.
    The study investigated a new combination therapy for treating scalp Alopecia Areata (AA) by combining high negative pressure microdermabrasion (MD) with intralesional steroid (ILST) injections. The researchers compared the effectiveness of this combination therapy to ILST alone. The results indicated that the combination therapy showed improved hair regrowth outcomes compared to ILST alone, suggesting that the addition of MD could enhance the therapeutic effects of ILST in treating AA. This study provided a promising new approach for managing AA, which affects 0.1-0.2% of the population and has been increasing in incidence.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community *WOMEN* on Spironolactone - experiences?

       6 upvotes 9 years ago
      Hair loss treatments discussed: Minoxidil, Finasteride, RU58841, and Spironolactone. Woman with androgenetic alopecia and alopecia areata shares experience using Spironolactone.

      community Fuck hair loss; acquire beard.

      in Shaved/buzzed  933 upvotes 2 years ago
      A user's transformation from an accountant to a spartan with a full beard, discussing the potential of DUPA and alopecia areata, as well as treatments like vitamins, topicals, and natural treatments for potential regrowth.

      community DHT and 5AR respect post, it's importance within the brain

      in Research/Science  111 upvotes 8 months ago
      The conversation discusses whether to use finasteride for hair loss, considering its role in inhibiting DHT and 5AR, which can affect brain function and mood. Some users report anxiety and depression from finasteride, while others do not experience these side effects and emphasize the importance of DHT for brain and prostate health.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 3 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

    Similar Research

    5 / 1000+ results